Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.69 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.63 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.62 |
| ▸ | BCKDK | O14874 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | PRNP | P04156 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.43 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.43 |
| ▸ | RPA1 | P27694 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13662602 | 0.85 | GPR35 (0.54) | GPR35MCL1BCL2L1RXFP1BCKDK | |
| SCHEMBL1608352 | 0.84 | STING1 (0.57) | GPR35MCL1BCL2L1RXFP1BCKDK | |
| SCHEMBL13659636 | 0.82 | GPR35 (0.51) | GPR35MCL1BCL2L1RXFP1BCKDK | |
| SCHEMBL14703004 | 0.81 | GPR35 (1.00) | GPR35MCL1BCL2L1RXFP1BCKDK | |
| SCHEMBL417349 | 0.77 | MCL1 (1.00) | MCL1BCL2L1RXFP1BCKDKNPSR1 | |
| SCHEMBL5224932 | 0.77 | STING1 (0.69) | GPR35MCL1BCL2L1RXFP1BCKDK | |
| SCHEMBL6886010 | 0.76 | MCL1 (1.00) | MCL1BCL2L1RXFP1BCKDKMAPK1 | |
| Hydrochloric Acid SCHEMBL11398368 | 0.76 | MCL1 (0.97) | MCL1BCL2L1RXFP1BCKDKNPSR1 | |
| SCHEMBL6840188 | 0.76 | MCL1 (0.60) | GPR35MCL1BCL2L1RXFP1BCKDK | |
| SCHEMBL6840187 | 0.76 | MCL1 (0.60) | GPR35MCL1BCL2L1RXFP1BCKDK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318785-B2 | Pharmaceutical compounds | ORION CORPORATION (FI) | 2012-11-27 | — | — | US | disclosed |
| US-20110086852-A2 | PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2011-04-14 | — | — | US | disclosed |
| EP-1910325-B1 | NEW PHARMACEUTICAL COMPOUNDS | ORION CORP (FI) | 2010-10-06 | — | — | EP | disclosed |
| US-20090247513-A1 | BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY | GENESOFT PHARMACEUTICALS, INC. (US) | 2009-10-01 | — | — | US | disclosed |
| US-20090247513-A1 | BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY | GENESOFT PHARMACEUTICALS, INC. (US) | 2009-10-01 | — | — | US | disclosed |
| US-7329765-B2 | Benzothiophene compounds having antiinfective activity | GENESOFT PHARMACEUTICALS, INC. (US) | 2008-02-12 | — | — | US | disclosed |
| US-7329765-B2 | Benzothiophene compounds having antiinfective activity | GENESOFT PHARMACEUTICALS, INC. (US) | 2008-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247513-A1 | BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY | TOP2A, TOP1, TOP2B | GPR35 2843/4885MCL1 951/4885BCL2L1 142/4885 |
| US-20110086852-A2 | PHARMACEUTICAL COMPOUNDS | COMT, CYP2C19, CYP3A4 | GPR35 889/4885MCL1 4587/4885BCL2L1 4512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.